Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies

We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.

Stanford is now accepting new patients for this trial. Please contact Jason D Merker at 650-922-1885 for more information.

Investigator(s):

Intervention(s):

  • procedure : Skin Biopsy
  • procedure : Blood Draw

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

1. 18 years of age or older 2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder being examined. 3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.

External Links

Explore related trials

Contact information

Primary Contact:

Jason D Merker 650-922-1885

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: